Loading Events
1/6/2026 - 30/6/2026

13th Call for Applications for GILEAD Scholarships for Biomedical Research in HIV, Hematology-Oncology, and Medical Oncology

Project Manager: Alejandro Villoria (proyectos@ibsal.es)
Scope: National
Type: Private
Area: Research project
Funding Organization: GILEAD SCIENCES
Funding: €50,000 per project
Submission Deadline:
from June 1, 2026, to June 30, 2026

Share in:

Purpose

The 13th Call for Applications for Gilead Scholarships for Biomedical Research in HIV, Hematology-Oncology, and Medical Oncology aims to promote the development of clinical research in these areas in our country.

 

Eligibility Requirements for Beneficiaries

The following are eligible for the grants included in this Call for Proposals: research project proposals carried out within Spain at Spanish healthcare facilities and submitted by nonprofit organizations and entities eligible for patronage listed in Articles 2 and 16 of Law 49/2002, of December 23, on the tax regime for nonprofit entities and tax incentives for patronage, provided they meet the requirements set forth in Article 3 of said law. In particular, and taking into account the provisions of the aforementioned regulations, as well as the scope of this Call for Grant Applications, the following entities are included:

  • The Foundations
  • Associations recognized as being of public benefit.
  • Federations and associations of nonprofit organizations.
  • Public and private universities that meet the requirements.
  • Public Research Agencies under the General State Administration.

Health Research Institutes and Public Research Consortia affiliated with Public Research Organizations in the field of health sciences may also be eligible for the grants. In such cases, the legal or regulatory requirements applicable to those entities will be taken into account.

Grants may not be awarded to individuals, but only to the entities listed above, which must submit the documentation specified in the grant award procedure described in the “Grant Award and Notification” section of this call for applications.

 

Characteristics of Research Groups

All proposals submitted must fall into one of the following categories of research groups:

— Groups led by researchers born in 1986 or later, with a track record of scientific output that suggests they have the potential to become highly competitive groups; these groups must submit proposals for distinctive and innovative research initiatives that do not involve the breakup of preexisting groups.

— Regular groups (led by researchers born before 1986) that must meet the general conditions set forth in the various sections, with no additional specific requirements.

 

Requirements for Research Project Proposals

Nationwide research programs in the fields of HIV, hematology-oncology, and medical oncology, with a duration of no more than 24 months and conducted at Spanish healthcare facilities.

Eligible areas of research:

Proposals submitted under this call for proposals may only pertain to research projects conducted within the national territory and with an implementation period not exceeding 24 months. This period will begin on the date the Grant Agreement for activities of general interest is signed, as referred to in the “Grant Award and Notification” section of this website.

Projects must fall within one of the research areas defined below:

  • HIV: Research to improve understanding among the following populations of people living with HIV (PLHIV)
  • Research on innovative care strategies that reduce the frequency of hospital visits or optimize the use of healthcare system resources
  • Research proposals that analyze the needs and the psychosocial, individual, and structural factors that influence access to, non-initiation of, adherence to, or discontinuation (DC) of PrEP
  • Hematology-Oncology: B-Cell Lymphomas (Diffuse Large B-Cell Lymphoma, Primary Mediastinal B-Cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma)
  • Medical Oncology (Solid Tumors)

 

Exclusion of projects:

— To evaluate drugs that are on the market or in development, regardless of whether they are owned by GILEAD, another pharmaceutical company, or another entity, organization, or academic institution.
— Submitted by a researcher who was a member of the research team for a project that received funding in the previous year’s call for proposals.

— Submitted by a researcher who is awaiting the submission of the final scientific and/or financial report for a Gilead grant that has already ended.

 

Ways to Participate

Research project proposals may be submitted in one of the following formats:

  • Single-center study: a project submitted by a single beneficiary applicant in accordance with the provisions of Rule 2 of this call for proposals, and conducted at a single clinical care center. Such projects may involve subcontracting; the grant recipient must ensure that subcontracting is carried out in accordance with applicable laws and regulations.
  • Multicenter study: a project proposed by a single beneficiary applicant in accordance with the provisions of Rule 2 of this call for proposals and conducted at multiple clinical care centers. The coordinating center must list the participating centers in the application.

 

Number of projects to be submitted

A maximum of two projects may be submitted per therapeutic area and healthcare facility. A healthcare facility is defined as the one to which the project’s principal investigator is affiliated. Each principal investigator may submit only one research project proposal.

 

Maximum number of grants to be awarded

At most, only one project may be awarded per therapeutic area and per healthcare facility. A healthcare facility is defined as the one to which the project’s principal investigator is affiliated.
Two projects from the category of “research groups led by researchers born in 1986 or later” will be selected for funding ; these will be the projects that have received the highest scores , regardless of the research area.

Subsequently, the remaining projects will be selected based on the scores they receive and the availability of funding by research area, regardless of the principal investigator’s age.

 

Funding

A variable amount that may not exceed 55,000 euros per project. This grant is compatible with other grants, subsidies, income, or resources of a public or private nature.

 

Deadline and Submission of Applications

Applications to participate in this call for proposals must be submitted online through this website from June 1 to June 30, 2026. www.BecasGileadInvestigacion.es,

For this Thirteenth Call for Proposals , all information must be submitted in English (project proposal and researchers’ CVs); therefore, projects submitted in any language other than English will not be evaluated.

Each principal investigator may submit only one research project proposal. A maximum of two projects may be submitted per therapeutic area and healthcare facility. A “healthcare facility” is defined as the facility to which the project’s principal investigator is affiliated.

At most, only one project may be awarded per therapeutic area and per healthcare facility to which the project’s principal investigator is affiliated.

For each application, applicants must indicate the category of research group in which they participate (a group led by researchers born in 1986 or later, or a group led by researchers born before 1986).

The information required for an application to be evaluated is as follows:

  • Research Project Report in accordance with the provided template (in English).
  • Curriculum Vitae (CVA-ISCIII), automatically generated by the CVN editor (http://cvn.fecyt.es/editor) or from any institution certified under the FECYT’s CVN standard that offers the CVA-ISCIII service, for the principal investigator and all other collaborators (in English).
  • Authorization from the director of the healthcare facility where the project will be carried out, in accordance with the provided template.
  • Articles of Incorporation of the applicant organization.
  • Power of representation of the entity’s signatory.
  • Registration of said entity in the appropriate registry.
  • Certificate of Public Benefit Status for Associations.

 

TERMS AND CONDITIONS OF THE CALL FOR APPLICATIONS